Buyers should understand it represents chiropractic and functional medicine expertise, not endocrinology or bariatric medicine
The benefits of GLP-1 medications in (overweight or obese) women with PCOS may include: While we need more research on GLP-1s and fertility in non-PCOS populations and women seeking fertility treatments, there is ample evidence for women with PCOS using GLP-1 medications for weight loss that the benefits extend to fertility as well
A multicenter, randomized, open-label, phase 3 trial (LIBRETTO-531) is ongoing to compare selpercatinib to cabozantinib or vandetanib in patients without prior kinase inhibitor therapy in RET -mutant MTC (NCT04211337)
It should also be noted that GLP is one of those brands which, in order to fight against low-end and cheap competition, have been able to evolve by producing well-finished, high-performance products at an attractive price
10.1136/bmj.j783 [DOI] [PMC free article] [PubMed] 68.Manski-Nankervis JA, Furler J, ONeal D, Ginnivan L, Thuraisingam S, Blackberry I
Similar to patients with diabetes mellitus, those with obesity taking GLP-1 RAs have a significant reduction in MACE, all-cause death, myocardial infarction, and revascularisation, without significant differences in rates of cardiovascular death or stroke